Macrogenics (MGNX) Income towards Parent Company (2012 - 2026)

Macrogenics' (MGNX) quarterly Income towards Parent Company came in at -$38.9 million in Q1 2026, up 8.91% year-on-year from -$35.7 million in Q1 2025, and down 175.42% on a QoQ basis from -$14.1 million in Q4 2025.

Macrogenics (MGNX) Income towards Parent Company (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has 15 years of Income towards Parent Company data on file, last reported at -$38.9 million in Q1 2026.

  • On a quarterly basis, Income towards Parent Company rose 8.91% year-over-year to -$38.9 million in Q1 2026; TTM through Mar 2026 was -$72.5 million, a 26.04% decrease from a year earlier, with the FY2025 full-year figure at -$74.6 million, down 11.39% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at -$38.9 million, down from -$14.1 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for MGNX reached as high as $56.3 million in Q3 2024 and fell as low as -$100.2 million in Q1 2024.
  • Historically, Income towards Parent Company has averaged -$31.2 million across 5 years, with a median of -$38.9 million in 2026.
  • Across the five-year window, Income towards Parent Company slumped 511.87% in 2023 and soared 258.61% in 2024, its largest moves.
  • Year by year, Income towards Parent Company stood at $12.0 million in 2022, then slumped by 511.87% to -$49.4 million in 2023, then surged by 68.75% to -$15.4 million in 2024, then grew by 8.39% to -$14.1 million in 2025, then tumbled by 175.42% to -$38.9 million in 2026.
  • Per Business Quant data, the three most recent Income towards Parent Company figures were -$38.9 million in Q1 2026, -$14.1 million in Q4 2025, and $16.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Macrogenics 255.39 Mn 188.87 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -38.91 Mn
Dec 31, 2025 -14.13 Mn
Sep 30, 2025 16.82 Mn
Jun 30, 2025 -36.25 Mn
Mar 31, 2025 -42.72 Mn
Dec 31, 2024 -15.42 Mn
Sep 30, 2024 56.31 Mn
Jun 30, 2024 -55.66 Mn
Mar 31, 2024 -100.20 Mn
Dec 31, 2023 -49.35 Mn
Sep 30, 2023 -35.50 Mn
Jun 30, 2023 -47.06 Mn
Mar 31, 2023 -46.25 Mn
Dec 31, 2022 11.98 Mn
Sep 30, 2022 -24.96 Mn
Jun 30, 2022 -41.81 Mn
Mar 31, 2022 -67.54 Mn
Dec 31, 2021 -385.83 Mn
Sep 30, 2021 -72.91 Mn
Jun 30, 2021 -94.21 Mn